Statement Of Cash Flows [Abstract]

Redcare Pharmacy N.V. - Filing #2154233

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-01-01
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
61, 456 EUR
2 9 , 1 1 2 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
23 , 4 41 EUR
6,0 17 EUR
Purchase of property, plant and equipment, classified as investing activities
6 ,437 EUR
1 3 , 5 6 5 EUR
Purchase of intangible assets, classified as investing activities
31 ,784 EUR
39,959,000 EUR
Interest received, classified as investing activities
4, 639 EUR
313,000 EUR
Cash flows from (used in) investing activities
59, 963 EUR
13 8 ,0 09 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
29,3 91 EUR
0 EUR
Payments of lease liabilities, classified as financing activities
7, 3 0 3 EUR
5,461,000 EUR
Interest paid, classified as financing activities
8, 022 EUR
7, 0 6 8 EUR
Cash flows from (used in) financing activities
15,046,000 EUR
1 3 ,5 15 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
16 ,5 3 9 EUR
18 0, 63 6 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
844,000 EUR
0 EUR
Cash and cash equivalents
84,160,000 EUR
66,777,000 EUR
66,7 77 EUR
247 ,413 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.